PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; and manufacturing of key intermediates and APIs.
Founded in 2006 in Nanjing, PharmaBlock is committed to helping its worldwide customers maximize the discovery and development efficiency of making next generations of medicines. It has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Continuing on that success and to provide a more comprehensive and long-term service to valued customers, the company established BTC Pharmaceutical Co., Ltd. in Nantong, Jiangsu province as its pilot plant site in 2015, and acquired Shandong Diai Biotechnology Co., Ltd. in Dezhou, Shandong province as its manufacturing site in 2016.
PharmaBlock has partnered with over 80% of the top 20 pharmaceutical companies, and hundreds of small to medium-sized biotechs around the world. In 2011, the company opened a new facility in the San Francisco Bay area, aiming for more efficient and timely services to local customers in the United States and Europe.
PharmaBlock Owned Companies
Shandong Diai Biotechnology Co., Ltd.